Рет қаралды 5,121
Scleroderma is a widely heterogeneous disease with only subsets of patients who develop some of the major organ complications. In this session, we will review how you and your physician can better predict your disease course and how we use screening tools to monitor disease. Laura Hummers, M.D.,Sc.M. 2021 National scleroderma Conference